key: cord-1007536-pj89j46s
authors: Tyagi, Sunil
title: Global research output in ‘pharmacovigilance’ during 2015-2020
date: 2021-12-15
journal: Therapie
DOI: 10.1016/j.therap.2021.11.011
sha: 96f42b732f48cd38b0e13cee62671c0ef661e31e
doc_id: 1007536
cord_uid: pj89j46s

The rapid spread of Covid-19 pandemic globally has thrust drugs safety into the spotlight and the public is now more aware of the role of healthcare professionals and health regulators. The present study aimed to measure the global research landscape on pharmacovigilance (PV) indexed in Scopus database for eleven years period spanning from 2010-2020. The study has sought to use quantitative and visualization technologies for data analysis and interpretation. The search strategy accumulated a total of 2052 global publications data on PV. The findings disclose that the global research productivity on PV registered 8.74% average growth rate (AGR) and 7.38% compound average growth rate (CAGR). The mean relative growth rate (RGR) and doubling time (DT) of PV global publications for the 11 years is 0.27 and 3.03, respectively. The average number of authors per paper (AAPP) is 1.52 and average productivity per author (PPA) is 0.68. The authorship patterns in PV research shows collaborative trend as the most of the publications have been published by multiple authors (80.75%). The mean values of degree of collaboration (DC), collaboration index (CI), collaboration coefficient (CC) and modified collaboration coefficient (MCC) during the selected period of study are 0.79, 2.74, 0.72, and 0.73, respectively which highly significant and indicates the better authorship collaborations. France is the bellwether in PV related scientific research as produced the highest number of publications.

Pharmacovigilance (PV) is an arm of patient care in making the rational use of medicines for the prevention of disease. In the recent times, the PV is of great importance as it is a key element in the regulation of effective drug use systems for the detection and prevention of adverse drug reactions (ADRs). According to the World Health Organization (WHO), ADRs defines as "a response to a drug which is noxious and unintended and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for the modifications of physiological function" (as cited by Ibrahim et al. [1] ). As per the WHO, ADRs are responsible for a significant number of hospital admissions ranging between 0.3≥11 percent [2] [3] ). The WHO has defined the PV as "the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine related problem" ( [4] ).

PV is all about the safer and more effective use of medicines for everyone. PV has been regarded as a continuous monitoring of undesired effects and drugs safety related issues. Therefore, the development of PV within a public health programme should be seen as an important opportunity towards the development of PV within the local health service of a comprehensive National PV System and should be seen as an obligatory investment in the future public health of patients or consumers (the end users of the pharmaceutical products) are now reporting the ADRs [7] . The healthcare professionals are the cornerstones in detection and reporting of ADRs to ensure medications safety [8] .

To coordinate, report and monitoring ADR detection at global level, the World Health Organization (WHO), Geneva has established the pharmacovigilance (PV) unit at Uppsala Monitoring Center (UMC), Sweden. The current global network consisting of 145 countries have been reporting ADRs to the UMC, Sweden [6] .

Within the pharmaceutical field, PV deserves a special attention, as it monitoring the performance of the pharmaceutical products that already available in the market. Although the pharmaceutical products are formulated to prevent, alleviate and to cure the illnesses but even can produce undesirable harmful effects. This duality of pharmaceutical products has significant for the public health and makes PV as an essential activity for health regulation in the country. Through early detection of the risk and timely intervention, the PV protects population from the damage caused by the pharmaceutical products.

In the current scenario, the clinical trials in drug therapy or drug discovery against novel corona virus prove the importance of PV. The global devastating impact of coronavirus disease 2019 (COVID- 19) pandemic has been pushed the PV to innovate and develop new and more efficient ways for collecting and utilizing the drug's safety data. It's a global concern that sufficient information related to safety of therapies or different treatment alternatives being used for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is limited. In light of the rapid drug discovery process (vaccine or drugs) across the globe, it is crucial that countries must share relevant ADRs in a time bound manner towards better understanding the efficacy and safety of the treatment or therapies used against the COVID-19 to manage long-term and pre-existing conditions.

WHO-UMC has provided useful information and issued necessary guidelines to perform the PV work during this COVID-19 pandemic, these include the following:

 Medicines safety during COVID-19;

 How to capture adverse event reports (coding guidance) for COVID-19 treatments; and  How to find adverse event reports linked to COVID-19 in VigiLyze (application used to visualize and analyze the drug safety data in COVID-19).

The rapid spread of COVID-19 pandemic globally has thrust drugs safety into the spotlight and the public is now more aware of the role of health professionals and health regulators. Therefore, the PV experts, clinicians, stakeholders and drug regulators needed to collaborate and assess the suspected ADRs timely to the success of public health across the globe.

In the scientific scenario, the production of the thematic area of PV has increased significantly over the past years therefore, it is essential to evaluate this production. In fact, a limited number of bibliometric studies carried out to measure the quality and impact of PV and ADRs related research activities have concentrated on the traditional bibliometric investigations extricated data from Web of Science, Scopus and PubMed database. Therefore, the present study has tried to bridge the research gap and studies the collaborative networks using the knowledge mapping techniques.

In light of the rapid drug discovery process (vaccine or drugs) across the globe, prove the importance of PV in relation to safety of therapies or different treatment alternatives being used for the COVID-19 infections. Therefore, PV across the world has become the important public health issue concern to regulators, drug manufacturers and the healthcare professionals. In light of its increasing relevance, the present study is an effort to evaluate the global research productivity in PV and assess the current research trends on a set of quantitative and qualitative metrics to provide some insights into the complex dynamics of research productivity on PV.

A limited number of bibliometric analyses related to PV, ADRs and medication errors have been carried out. Huang, Du and Cong [9] analyze the global research trends of PV in China and identified the growth in hospitals, pharmaceutical enterprises and of the opinion that the collaborations between institutions were tight. Zheng, Cheng and Song [10] in analyzing the current status and shortcomings of PV research in China, revealed that the PV research in China still focuses on traditional adverse drug reactions monitoring. The global research growth and patterns on systemic use of off-label and unlicensed drugs has witnessed a general increase in the past two decades [11] .

Shrestha et al [12] emphasized that there is a need to study and evaluate ADR and PV in Nepal to improve PV practice and to promote the quality use of medicines. Zhang et al. [13] stressed that the comprehensive features and the risk factors of cardiac ADRs induced by oral Chinese Materia Medica can be elucidated through the approaches of bibliometric research towards creating awareness of PV. Chen et al. [14] in the field of event detection in social media (ED in SM) identified PV event detection as newly emerged themes among the 14 identified research themes. AlHusaini and AlMubarak [15] emphasized that education on ADRs medical safety are necessary for the population for gaining more awareness of consequences of ADRs and for the healthcare provider to give a clear and accurate information to the patients.

Moore et al. [16] reported that the discovery and quantification of ADRs has long relied on the careful analysis of spontaneously reported cases and the spontaneous reporting remains irreplaceable in signal and alert generation in drug safety. The availability of large databases and computerized automated statistical approaches has modified the assessment of drug safety and of their benefits harms balance [17] . Abou Taam et al. [18] reported that due to paradigm shift in the assessment and management of patient related drug safety, the importance of pharmacoepidemiology and its use in pharmacovigilance has significantly increased.

Lefebvre et al. [19] to enhance the effectiveness of PV programs, clustered the 1244 respondents into 4 segments: not engaged (12%), low-involvement users (29%), careful users (50%) and social information seekers (9%) distinguishing by perceived seeking control, self-appraisal of skill, information insufficiency, self-efficacy, information competency and health literacy towards identifying for prescription drug safety social marketing and communication activities. The result shows significant differences among the segments in their comprehension and perceived utility.

Wilbur, Sahal and Elgaily [20] explore how the pharmacists identify, prioritize and communicate ADRs to patients in a Doha hospital, Qatar. They found that expert cardiology pharmacists used widely accessible resources during choosing the most commonly reported ADR to communicate during medication counselling. Shang, Chen and Livoti [21] proposed a framework to detect Avandia ADRs using Google Trends to early identify the ADR events and the resultant data proved to have a longer leading time than the traditional drug reaction discovery methods.

The research related to detection methods of cardiotoxicity and preventive drugs is gradually increasing [22] . With the extensive digitalization of medical information globally, the natural language processing is becoming more crucial [23] . Santos et al. [24] highlights the significant inpatients. More research on implementing patient safety improvement initiatives might be needed [26] .

The main objective of the study is to measure the global research landscape in the field of PV as  To identify the prominent research themes using the keywords analysis.

The global research publications data on PV was retrieved and downloaded from Scopus database for the period from 2010-2020 using "date range tag". The Scopus database was used as a tool to retrieve potential publications as Scopus database in terms of wide global coverage of scientific journals, is the largest abstract and citation databases. The search string used for the purpose the preset query sets. The study has sought to use quantitative and visualization technologies for data analysis and interpretation. Network visualization maps including research collaboration of authors, journals, institutions and countries were created by using the VOSviewer program. The study has also made use of analytical provisions as available in the Scopus database [27] .

Author has used two bibliometric indicators in the present study. These are total number of publications (TNP) and total number of citations (TNC) for measuring the scientific output and impact. Besides these bibliometric indicators, two relative indicators viz average citations per paper (ACP) and relative citation impact (RCI) have also been used. Various scientometric parameters have also been applied such as average growth rate (AGR), compound average growth rate (CAGR), relative growth rate (RGR), doubling time (DT), Pearson correlation, authors' productivity and explored statistical techniques for the present study. To measure collaboration patterns among authors; degree of collaboration (DC), collaboration index (CI), collaboration coefficient (CC), and modified collaboration coefficient (MCC) methods used.

The study presents the types of publications in PV related global scientific research output during the study period from 2010-2020. Ten (n = 10) types publications excluding undefined category (Table 1) .

The journals considered as the vital source and main channel of information towards disseminating Table 2) . Table 3 Therefore, it revealed from the data that as the relative growth of publications decreased, simultaneously, the corresponding doubling time of publications will increased. The mean RGR and DT of PV publication for 11 years is 0.27 and 3.03, respectively (Table 4 ).

It has been inferred from the data that the total average number of authors per paper (AAPP) is 1. (Table 6) .

Pearson correlation analysis used to evaluate the correlation between number of papers and the number of authors. The resultant data inferred significant and positive relationship (r = 0.738, N = 11, p = 0.009). As the p-value is <0.05, therefore, it is highly significant. It means that the higher numbers of co-authors were contributed to the higher number of papers (Table 7) .

It is imperative that contributions by authors in PV related literature have spanned across the globe. The analysis also discloses that most of the productive authors in the list belong from France (7 authors), followed by Germany (2 authors) and 1 from Sweden. RCI is an indicator (developed by Thomas Reuters erstwhile Institute of Scientific Information) used to measure the impact of research production of nations/institutions/authors/journals. The authors having RCI<1 implies that the research output was not commensurate with their impact, whereas, authors having RCI>1 indicates the high impact research (Table 8) .

There were 47 authors meeting the threshold of a minimum of 10 documents per author and grouped into clusters, where cluster indicates group of closely collaborating authorship [34] . The co-authorship network of authors in the field of PV is visually depicted in Fig. 1 . Out of the total 3038 authors, 47 meet the criteria; however, only 38 items are seen to be connected in terms of collaboration. The network visualization map demonstrates the strength of collaboration between 38 authors, distributed across 5 clusters, coloured differently, with 142 links and total link strength (TLS) of 572 (Fig. 1) .

In all, a total of one hundred fifty two (n = 152) countries contributed unevenly in global PV scientific research. The countries were ranked according to the descending order of their total publications. The top ten countries share ranging between 77≥373 publications reflect the major has the highest 1.82 RCI followed by Switzerland with 1.54. The countries having RCI<1 implies that the research output was not commensurate with their impact, whereas, countries having RCI>1 indicates the high impact research (Table 9 ).

Wang and Chang [35] The big nodes represent the dominant countries. The links between the nodes represent the cooperative relationship in PV research. The distance between the nodes and thickness of the links symbolize the cooperative level among the countries (Fig. 2) .

The total number of PV focused publications was produced by 5322 organizations. The The data also exposes that most of the organizations in the list belong from France; therefore, it revealed that France is the bellwether in PV related scientific research and indicating the significant efforts of these organizations. Except one, all the organizations exhibit RCI>1, indicates the high impact research (Table 10) .

The network visualization mapping among the organizations in the field of PV research has been visually depicted in Fig. 3 . The map has been created with a threshold of 2 documents per organizations and out of the total 5322 organizations, 384 meet the criteria. However, only 49 items are seen to be connected in terms of collaboration. The map demonstrates the strength of collaboration between 49 organizations, distributed across 11 clusters, coloured differently, with 85 links and TLS of 96. The organizations have shown the weak collaboration (Fig. 3) .

The PV focused research publications were produced in 1862 journals and the top 10 productive journals depicted in Table 11 . According to the Bradford's Law, the journals were ranked in terms of the decreasing order of their productivity. The resultant data inferred that the most productivity implies that the research output was not proportional with their impact, whereas, RCI>1 indicates the high impact research (Table 11 ).

The journal co-citation analysis was performed using citation as the unit of analysis in the counting method in order to identify the core journals by using the minimum threshold number of 100 (Fig. 4) .

Co-occurrence of keywords provides the secondary support to understand the scientific research (Table 12 ; Fig. 5 ). Table 13 demonstrated the top 10 most crucial research areas in PV. The broad ranging scope of PV remains a dynamic medical discipline to prevent ADRs in human beings, to promote patient safety and also in promoting rational use of quality medicines. The findings revealed that there is a considerable research output in the area of medicine with a proportion of 48.33 per cent (n = 1563) J o u r n a l P r e -p r o o f papers of the total publications, followed by pharmacology, toxicology and pharmaceutics accounting for 30.30 per cent (n = 980) publications share. Other subject areas appearances ranging between 3≥138 publications share. The figures revealed that PV research in the areas of medicines is in full bloom and in pursuant to this, the researchers and scientists are constantly carrying out the research for better mechanism towards safeguard of the public health (Table 13) .

Table-14 recorded the top 10 most cited research papers in PV that registered citations between 130≥330 citations. The citation per year (CPY) is also calculated to overcome the problem encountered during variation of citations (Garg and Tripathi, 2017 [37] ). Highly cited papers accumulated a sum of 2033 (14.46%) citations during the time span 2010-2020. All these highly cited papers were collaborative papers. The table shows that the research paper entitled "Pharmacovigilance from social media: Mining adverse drug reaction mentions using sequence labeling with word embedding cluster features" by Nikfarjam et al. [38] was the most cited publication with 308 citations, followed by "Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study by Salem et al. with 300 citations [39] (Table 14) .

Of the retrieved total 2052 documents, 27.63 per cent (n = 567) publications were the funded projects. The National Institute of Health (NIH) with a proportion of 1.90 per cent (n = 39) publications was the most active funding agency in PV research at global level.

The recommendations for improving ADR reporting system working under the umbrella of PV mechanism of country are as under:

 Every governmental and the private hospital should established a PV centre for ADRs reporting;

 PV workshops/seminars/conferences/webinars should be conducted time to time to create awareness and to guide healthcare professionals;  Patient should be encouraged for self-reporting alongside reporting by healthcare professionals;

 Comprehensive national PV programs should be initiated;

 PV specialists should guide healthcare professionals;

 New modern technology should be incorporated to facilitate ADRs reporting;

 Education on PV should be introduced in pharmacy curricula;

 ADRs reporting should be made compulsory for all the pharmaceutical companies and healthcare professionals.

The Based on the co-occurrence of keywords analysis, the most important author keywords were 'pharmacovigilance' and 'adverse drug reactions'. The broad ranging scope of PV remains a dynamic medical discipline to prevent ADRs in human beings, to promote patient safety and also in promoting rational use of quality medicines. The findings revealed that there is a considerable research output in the area of medicine with a proportion of 48.33% papers. The PV research in the areas of medicines is in full bloom and in pursuant to this, the researchers and scientists are constantly carrying out the research for better mechanism towards safeguard of the public health.

The rapid spread of COVID-19 pandemic globally has thrust drugs safety into the spotlight and the public is now more aware of the role of healthcare professionals and health regulators.

Amid new drugs discovery process against COVID-19, it needs to be ensuring the efficacy and safety of the drugs during clinical trials of the drugs and even in the post-marketing period for the safeguard of the public health. The monitoring of safety of therapies or treatment being given to corona patient is crucial and facing challenges. Monitoring of the safety of medicinal products is an ongoing process and enormous safety related data gathered during clinical trials from different Page 21 of 38 J o u r n a l P r e -p r o o f patient population at global level, therefore, a systematic approach to PV should be implemented to identify the ADRs for taking appropriate action to reduce risk and increase benefits associated with the medicines. Therefore, it is needed that the PV experts, clinicians, stakeholders and drug regulators collaborate in the assessment of suspected ADRs timely to reduce risks and increasing benefits associated with the medicinal products towards success of public health across the globe.

Further, to generate substantial amount of data, electronic means of reporting must be enhanced in the present time.

The global phenomenon of PV is attracting the scientists of similar interest for collaborative research across the globe towards safeguard of the public health. Although, due to advancement in measuring safety use of medicines or due to 'publish or perish' scientific community's keen interest, the PV research productivity enhancing with every passing day. The study exposes that the PV research is in full bloom and recommended that the scientometric assessment will have to examine the research progress at regular intervals focussing on quantitative and qualitative indicators of publications. The present scientometric assessment is based solely on the literature indexed in the core collection of Scopus database and although the literature available in other databases like Web of Science (WoS) and PubMed as well may be harvested in future research.

Overall, this study has led us to grasp the current trends of PV research. The outcome of the study may help drug manufacturers, medical scientists, drug regulators and health-care professionals to identify current research progress in PV at global level. In addition, it will also help to identify the most prolific authors, institutions, countries and channels of communication in the development of research. PV is a global developing field with significant future research. 

Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?

Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes

Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18820 patients

Regulation and prequalification: What is pharmacovigilance. 2021. www.who.int/teams/regulation-prequalification/regulation-andsafety/pharmacovigilance

The safety of medicines in public health programmes: Pharmacovigilance an essential tool

Uppsala monitoring centre: Global pharmacovigilance

Pharmacovigilance activities in 55 low-and middleincome countries: a questionnaire-based analysis

Importance of pharmacovigilance and the role of healthcare professionals

Analysis on global research trends of pharmacovigilance in recent five years and its implications for China

Bibliometric analysis of pharmacovigilance research in China

Global research publications on systemic use of off-label and unlicensed drugs: A bibliometric analysis (1990-2020)

Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal

The characteristics and regularities of cardiac adverse drug reactions induced by Chinese materia medica: A bibliometric research and association rules analysis

A bibliometric analysis of event detection in social media

Public awareness of adverse drug reaction medical safety

Pharmacovigilance -The next chapter

Uses of pharmacovigilance databases: An overview

Interest of pharmacoepidemiology in pharmacovigilance: Post-authorization safety studies in regulatory pharmacovigilance activity

A quantitative approach to segmentation for prescription drug safety programs

Communicating medication risk to cardiovascular patients in Qatar

Adverse drug reaction early warning using user search data

Bibliometric analysis of the results of cardiooncology research

Systematic evaluation of research progress on natural language processing in medicine over the past 20 years: Bibliometric study on PubMed

Data mining and machine learning techniques applied to public health problems: A bibliometric analysis from

Bibliometric analysis of medication errors and adverse drug events studies

Mapping patient safety: a large-scale literature review using bibliometric visualisation techniques

Libr Hi Tech New

Research productivity of newly established central universities in India

The growing trend of India's participation in planetary science research

An analysis of the connection between researchers' productivity and their co-authors' past attributions, including the importance in collaboration networks

Bibliometric studies of research collaboration: a review

Collaborative coefficient: a single measure of the degree of collaboration in research

Global research productivity in cybersecurity: a scientometric study

A scientometric analysis of worldwide intercropping research based on Web of Science database between 1992 and 2020

Exploring a comprehensive knowledge map for promoting safety management research in the construction industry. Engin Constr Arch Management

Factors affecting number of citations: A comprehensive review of the literature

Addendum to bibliometrics and scientometrics in India during 1995-2014: An overview of studies during 1995-2014

Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study Salem

Utilizing social media data for pharmacovigilance: A review

Once-daily opioids for chronic dyspnea: A dose increment and pharmacovigilance study Currow

Listening to signals from the crowd White